<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36941021</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2053-8790</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Lupus science &amp; medicine</Title><ISOAbbreviation>Lupus Sci Med</ISOAbbreviation></Journal><ArticleTitle>Panoramic view of clinical features of lupus erythematosus: a cross-sectional multicentre study from China.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e000819</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/lupus-2022-000819</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Lupus erythematosus (LE) is a complicated disease with highly heterogeneous clinical manifestations. Previous studies have rarely included all subgroups of patients with lupus and have overlooked the importance of the cutaneous manifestations thereof. We aimed to compare the demographic and clinical differences among patients with different subtypes of lupus.</AbstractText><AbstractText Label="METHODS">This is the first real-world study with a relatively large sample size that simultaneously includes patients with isolated cutaneous lupus erythematosus (iCLE) and SLE. All samples were obtained from the Lupus Erythematosus Multicenter Case-control Study in Chinese populations (LEMCSC) (registration number: ChiCTR2100048939). Comparative analyses between different LE subgroups were performed.</AbstractText><AbstractText Label="RESULTS">A total of 2097 patients with lupus were included, with 1865 patients with SLE, 1648 with cutaneous lupus erythematosus (CLE), and 232 with iCLE. Among the patients with CLE, 1330 had acute cutaneous lupus erythematosus (ACLE); 160 had subacute cutaneous lupus erythematosus (SCLE); and 546 had chronic cutaneous lupus erythematosus (CCLE). The study included a relatively large number of patients with CCLE subtypes, including 311 with discoid lupus erythematosus (DLE), 262 with chilblain lupus erythematosus (CHLE) and 45 with lupus erythematosus profundus (LEP). Demographic characteristics, systemic involvement, mucocutaneous manifestations and autoantibodies were significantly different among the groups.</AbstractText><AbstractText Label="CONCLUSIONS">CLE and iCLE are two distinct disease states, and the selection of broad or narrow CLE definitions should be emphasised in scientific reports. LE-non-specific cutaneous lesions imply more severity, while self-reported photosensitivity and LE-specific cutaneous manifestations imply milder severity. Generalised ACLE appears to be a more severe state than localised ACLE, and CHLE appears to be more severe than DLE. Anti-Sj&#xf6;gren's syndrome-related antigen B (SSB) antibodies have higher specific directivity than anti-Sj&#xf6;gren's syndrome-related antigen A (SSA) antibodies for SCLE lesions. Anti-double-stranded DNA antibodies have a higher co-occurrence with ACLE and a lower co-occurrence with SCLE and CCLE. Compared with DLE, CHLE has significantly higher positive rates of anti-SSA/Ro60 (71%) and anti-SSA/Ro52 (42.4%) antibodies, whereas LEP is associated with a higher positive rate of antinucleosome antibodies (31.1%).</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Jin</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit of Key Technologies of Immune-related Skin Diseases Diagnosis and Treatment, Chinese Academy of Medical Sciences Institute of Dermatology, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Basic and Translational Research on Immune-Mediated Skin Diseases, Chinese Academy of Medical Sciences, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhou</LastName><ForeName>Shihang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit of Key Technologies of Immune-related Skin Diseases Diagnosis and Treatment, Chinese Academy of Medical Sciences Institute of Dermatology, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yu</LastName><ForeName>Yangyiyi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit of Key Technologies of Immune-related Skin Diseases Diagnosis and Treatment, Chinese Academy of Medical Sciences Institute of Dermatology, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Basic and Translational Research on Immune-Mediated Skin Diseases, Chinese Academy of Medical Sciences, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Haijing</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-6338-5089</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Hai</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Siqi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Ruifang</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Heng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Jieyue</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Shuangyan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Yixin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Shuaihantian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Fen</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ling</LastName><ForeName>Guanghui</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Qianjin</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-4192-4897</Identifier><AffiliationInfo><Affiliation>Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China qianlu5860@pumcderm.cams.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Basic and Translational Research on Immune-Mediated Skin Diseases, Chinese Academy of Medical Sciences, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ChiCTR</DataBankName><AccessionNumberList><AccessionNumber>ChiCTR2100048939</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus Sci Med</MedlineTA><NlmUniqueID>101633705</NlmUniqueID><ISSNLinking>2053-8790</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008178" MajorTopicYN="Y">Lupus Erythematosus, Cutaneous</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008179" MajorTopicYN="Y">Lupus Erythematosus, Discoid</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012859" MajorTopicYN="Y">Sjogren's Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">autoimmune diseases</Keyword><Keyword MajorTopicYN="N">lupus erythematosus, systemic</Keyword><Keyword MajorTopicYN="N">lupus nephritis</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>20</Day><Hour>20</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36941021</ArticleId><ArticleId IdType="pmc">PMC10030678</ArticleId><ArticleId IdType="doi">10.1136/lupus-2022-000819</ArticleId><ArticleId IdType="pii">10/1/e000819</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tsokos GC. Autoimmunity and organ damage in systemic lupus erythematosus. Nat Immunol 2020;21:605&#x2013;14. 10.1038/s41590-020-0677-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0677-6</ArticleId><ArticleId IdType="pmc">PMC8135909</ArticleId><ArticleId IdType="pubmed">32367037</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitar C, Menge TD, Chan MP. Cutaneous manifestations of lupus erythematosus: a practical clinicopathological review for pathologists. Histopathology 2022;80:233&#x2013;50. 10.1111/his.14440</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/his.14440</ArticleId><ArticleId IdType="pubmed">34197657</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn A, Kuehn E, Meuth AM, et al. . Development of a core set questionnaire by the European Society of cutaneous lupus erythematosus (EUSCLE). Autoimmun Rev 2009;8:702&#x2013;12. 10.1016/j.autrev.2009.02.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2009.02.022</ArticleId><ArticleId IdType="pubmed">19232553</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Q, Long H, Chow S, et al. . Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus. J Autoimmun 2021;123:102707. 10.1016/j.jaut.2021.102707</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102707</ArticleId><ArticleId IdType="pubmed">34364171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn A, Landmann A. The classification and diagnosis of cutaneous lupus erythematosus. J Autoimmun 2014;48&#x2013;49:14&#x2013;9. 10.1016/j.jaut.2014.01.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2014.01.021</ArticleId><ArticleId IdType="pubmed">24486120</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin H, Zhang G, Zhou Y, et al. . Old lines tell new tales: blaschko linear lupus erythematosis. Autoimmun Rev 2016;15:291&#x2013;306. 10.1016/j.autrev.2015.11.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2015.11.014</ArticleId><ArticleId IdType="pubmed">26678347</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W, Wu H, Zhao M, et al. . New insights into the progression from cutaneous lupus to systemic lupus erythematosus. Expert Rev Clin Immunol 2020;16:829&#x2013;37. 10.1080/1744666X.2020.1805316</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2020.1805316</ArticleId><ArticleId IdType="pubmed">32746644</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek YS, Park SH, Baek J, et al. . Cutaneous lupus erythematosus and its association with systemic lupus erythematosus: a nationwide population-based cohort study in Korea. J Dermatol 2020;47:163&#x2013;5. 10.1111/1346-8138.15162</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1346-8138.15162</ArticleId><ArticleId IdType="pubmed">31773752</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xf6;nhagen CM, Fored CM, Granath F, et al. . Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. Br J Dermatol 2011;164:1335&#x2013;41. 10.1111/j.1365-2133.2011.10272.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2133.2011.10272.x</ArticleId><ArticleId IdType="pubmed">21574972</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarukitsopa S, Hoganson DD, Crowson CS, et al. . Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States. Arthritis Care Res (Hoboken) 2015;67:817&#x2013;28. 10.1002/acr.22502</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.22502</ArticleId><ArticleId IdType="pmc">PMC4418944</ArticleId><ArticleId IdType="pubmed">25369985</ArticleId></ArticleIdList></Reference><Reference><Citation>Biazar C, Sigges J, Patsinakidis N, et al. . Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the european society of cutaneous lupus erythematosus (EUSCLE). Autoimmun Rev 2013;12:444&#x2013;54. 10.1016/j.autrev.2012.08.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2012.08.019</ArticleId><ArticleId IdType="pubmed">23000206</ArticleId></ArticleIdList></Reference><Reference><Citation>Deligny C, Clyti E, Sainte-Marie D, et al. . Incidence of chronic cutaneous lupus erythematosus in French Guiana: a retrospective population-based study. Arthritis Care Res (Hoboken) 2010;62:279&#x2013;82. 10.1002/acr.20079</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.20079</ArticleId><ArticleId IdType="pubmed">20191529</ArticleId></ArticleIdList></Reference><Reference><Citation>Zian Z, Maamar M, Aouni ME, et al. . Immunological and clinical characteristics of systemic lupus erythematosus: a series from morocco. Biomed Res Int 2018;2018:3139404. 10.1155/2018/3139404</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/3139404</ArticleId><ArticleId IdType="pmc">PMC6186365</ArticleId><ArticleId IdType="pubmed">30363993</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca R, Aguiar F, Rodrigues M, et al. . Clinical phenotype and outcome in lupus according to age: a comparison between juvenile and adult onset. Reumatol Clin (Engl Ed) 2018;14:160&#x2013;3. 10.1016/j.reuma.2016.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.reuma.2016.10.011</ArticleId><ArticleId IdType="pubmed">28040420</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W-G, Ye Z-Z, Yin Z-H, et al. . Clinical and immunological characteristics in 552 systemic lupus erythematosus patients in a Southern Province of China. Int J Rheum Dis 2017;20:68&#x2013;75. 10.1111/1756-185X.12480</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.12480</ArticleId><ArticleId IdType="pubmed">25865002</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh AP, Nag F, Biswas S, et al. . Clinicopathological and immunological profile of patients with cutaneous manifestations and their relationship with organ involvement in systemic lupus erythematosus attending a tertiary care center of Eastern India. Indian J Dermatol 2020;65:22&#x2013;8. 10.4103/ijd.IJD_282_19</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijd.IJD_282_19</ArticleId><ArticleId IdType="pmc">PMC6986128</ArticleId><ArticleId IdType="pubmed">32029935</ArticleId></ArticleIdList></Reference><Reference><Citation>De Oliveira NT, Gomes Silva N, Dos Santos TAFG, et al. . Clinical and autoantibody profile in male and female patients with systemic lupus erythematosus: a retrospective study in 603 Brazilian patients. Eur J Rheumatol 2020;7:164&#x2013;8. 10.5152/eurjrheum.2020.20023</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/eurjrheum.2020.20023</ArticleId><ArticleId IdType="pmc">PMC7574763</ArticleId><ArticleId IdType="pubmed">32910762</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin H, Huang T, Wu R, et al. . A comparison and review of three sets of classification criteria for systemic lupus erythematosus for distinguishing systemic lupus erythematosus from pure mucocutaneous manifestations in the lupus disease spectrum. Lupus 2020;29:1854&#x2013;65. 10.1177/0961203320959716</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320959716</ArticleId><ArticleId IdType="pubmed">33028176</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin H, Zhao M, Lu Q. Clinical characteristics of 1006 Chinese patients with lupus erythematosus: results from the lupus erythematosus multicenter case-control study in Chinese populations (LEMCSC). Chin J Dermatol 2016;1:6&#x2013;11.</Citation></Reference><Reference><Citation>Hochberg MC. Updating the American College of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725. 10.1002/art.1780400928</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Orbai A-M, Alarc&#xf3;n GS, et al. . Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64:2677&#x2013;86. 10.1002/art.34473</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34473</ArticleId><ArticleId IdType="pmc">PMC3409311</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Kane D, McCourt C, Meggitt S, et al. . British association of dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021. Br J Dermatol 2021;185:1112&#x2013;23. 10.1111/bjd.20597</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.20597</ArticleId><ArticleId IdType="pubmed">34170012</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn A, Aberer E, Bata-Cs&#xf6;rg&#x151; Z, et al. . S2k guideline for treatment of cutaneous lupus erythematosus-guided by the European dermatology forum (EDF) in cooperation with the European Academy of dermatology and venereology (EADV). J Eur Acad Dermatol Venereol 2017;31:389&#x2013;404. 10.1111/jdv.14053</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.14053</ArticleId><ArticleId IdType="pubmed">27859683</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Zhang W, Leng X, et al. . Chinese SLE treatment and research Group (CSTAR) registry: I. Major clinical characteristics of Chinese patients with systemic lupus erythematosus. Lupus 2013;22:1192&#x2013;9. 10.1177/0961203313499086</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203313499086</ArticleId><ArticleId IdType="pubmed">23963101</ArticleId></ArticleIdList></Reference><Reference><Citation>Borba EF, Araujo DB, Bonf&#xe1; E, et al. . Clinical and immunological features of 888 Brazilian systemic lupus patients from a monocentric cohort: comparison with other populations. Lupus 2013;22:744&#x2013;9. 10.1177/0961203313490432</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203313490432</ArticleId><ArticleId IdType="pubmed">23687065</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xf6;nhagen CM, Gunnarsson I, Svenungsson E, et al. . Cutaneous manifestations and serological findings in 260 patients with systemic lupus erythematosus. Lupus 2010;19:1187&#x2013;94. 10.1177/0961203310367656</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203310367656</ArticleId><ArticleId IdType="pubmed">20501526</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch K, Tikly M. Spectrum of cutaneous lupus erythematosus in South Africans with systemic lupus erythematosus. Lupus 2019;28:1021&#x2013;6. 10.1177/0961203319856091</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203319856091</ArticleId><ArticleId IdType="pubmed">31215844</ArticleId></ArticleIdList></Reference><Reference><Citation>Maloney KC, Ferguson TS, Stewart HD, et al. . Clinical and immunological characteristics of 150 systemic lupus erythematosus patients in Jamaica: a comparative analysis. Lupus 2017;26:1448&#x2013;56. 10.1177/0961203317707828</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203317707828</ArticleId><ArticleId IdType="pubmed">28480787</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Wang CL, Tan CT, et al. . Systemic lupus erythematosus in Malaysia: a study of 539 patients and comparison of prevalence and disease expression in different racial and gender groups. Lupus 1997;6:248&#x2013;53. 10.1177/096120339700600306</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/096120339700600306</ArticleId><ArticleId IdType="pubmed">9104731</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Estel BA, Catoggio LJ, Cardiel MH, et al. . The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among &#x201c; Hispanics. &#x201d; Medicine (Baltimore) 2004;83:1&#x2013;17. 10.1097/01.md.0000104742.42401.e2</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.md.0000104742.42401.e2</ArticleId><ArticleId IdType="pubmed">14747764</ArticleId></ArticleIdList></Reference><Reference><Citation>Patsinakidis N, Gambichler T, Lahner N, et al. . Cutaneous characteristics and association with antinuclear antibodies in 402 patients with different subtypes of lupus erythematosus. J Eur Acad Dermatol Venereol 2016;30:2097&#x2013;104. 10.1111/jdv.13769</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.13769</ArticleId><ArticleId IdType="pubmed">27431977</ArticleId></ArticleIdList></Reference><Reference><Citation>Merola JF, Prystowsky SD, Iversen C, et al. . Association of discoid lupus erythematosus with other clinical manifestations among patients with systemic lupus erythematosus. J Am Acad Dermatol 2013;69:19&#x2013;24. 10.1016/j.jaad.2013.02.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2013.02.010</ArticleId><ArticleId IdType="pmc">PMC3686921</ArticleId><ArticleId IdType="pubmed">23541758</ArticleId></ArticleIdList></Reference><Reference><Citation>Wysenbeek AJ, Guedj D, Amit M, et al. . Rash in systemic lupus erythematosus: prevalence and relation to cutaneous and non-cutaneous disease manifestations. Ann Rheum Dis 1992;51:717&#x2013;9. 10.1136/ard.51.6.717</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.51.6.717</ArticleId><ArticleId IdType="pmc">PMC1004732</ArticleId><ArticleId IdType="pubmed">1616352</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel P, Werth V. Cutaneous lupus erythematosus: a review. Dermatol Clin 2002;20:373&#x2013;85, 10.1016/s0733-8635(02)00016-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0733-8635(02)00016-5</ArticleId><ArticleId IdType="pubmed">12170873</ArticleId></ArticleIdList></Reference><Reference><Citation>Tebbe B, Orfanos CE. Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 1997;6:96&#x2013;104. 10.1177/096120339700600204</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/096120339700600204</ArticleId><ArticleId IdType="pubmed">9061657</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanprapaph K, Tankunakorn J, Suchonwanit P, et al. . Dermatologic manifestations, histologic features and disease progression among cutaneous lupus erythematosus subtypes: a prospective observational study in Asians. Dermatol Ther (Heidelb) 2021;11:131&#x2013;47. 10.1007/s13555-020-00471-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13555-020-00471-y</ArticleId><ArticleId IdType="pmc">PMC7859020</ArticleId><ArticleId IdType="pubmed">33280074</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiewchengchol D, Murphy R, Edwards SW, et al. . Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature. Pediatr Rheumatol Online J 2015;13:1. 10.1186/1546-0096-13-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1546-0096-13-1</ArticleId><ArticleId IdType="pmc">PMC4292833</ArticleId><ArticleId IdType="pubmed">25587243</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Costenbader K, Johnson SR. Assessing the EULAR/ACR classification criteria for patients with systemic lupus erythematosus. Expert Rev Clin Immunol 2022;18:135&#x2013;44. 10.1080/1744666X.2022.2033617</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2022.2033617</ArticleId><ArticleId IdType="pubmed">35076341</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders CJG, Van Weelden H, Kazzaz GAA, et al. . Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol. Br J Dermatol 2003;149:131&#x2013;7. 10.1046/j.1365-2133.2003.05379.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2133.2003.05379.x</ArticleId><ArticleId IdType="pubmed">12890206</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakley AM, Badri T, Harris BW. Photosensitivity. In: StatPearls. Treasure Island (FL): StatPearls Publishing LLC. Copyright &#xa9; 2021, 2021.</Citation></Reference><Reference><Citation>Chanprapaph K, Ploydaeng M, Pakornphadungsit K, et al. . The behavior, attitude, and knowledge towards photoprotection in patients with cutaneous/systemic lupus erythematosus: a comparative study with 526 patients and healthy controls. Photochem Photobiol Sci 2020;19:1201&#x2013;10. 10.1039/d0pp00073f</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/d0pp00073f</ArticleId><ArticleId IdType="pubmed">32935699</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubey S, Joshi N, Stevenson O, et al. . Chilblains in immune-mediated inflammatory diseases: a review. Rheumatology (Oxford) 2022;61:4631&#x2013;42. 10.1093/rheumatology/keac231</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keac231</ArticleId><ArticleId IdType="pmc">PMC9383735</ArticleId><ArticleId IdType="pubmed">35412601</ArticleId></ArticleIdList></Reference><Reference><Citation>Yung S, Chan TM. Anti-dsdna antibodies and resident renal cells - their putative roles in pathogenesis of renal lesions in lupus nephritis. Clin Immunol 2017;185:40&#x2013;50. 10.1016/j.clim.2016.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2016.09.002</ArticleId><ArticleId IdType="pubmed">27612436</ArticleId></ArticleIdList></Reference><Reference><Citation>Avil&#xe9;s Izquierdo JA, Cano Mart&#xed;nez N, L&#xe1;zaro Ochaita P. Epidemiological characteristics of patients with cutaneous lupus erythematosus. Actas Dermosifiliogr 2014;105:69&#x2013;73. 10.1016/j.ad.2013.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ad.2013.09.005</ArticleId><ArticleId IdType="pubmed">24268922</ArticleId></ArticleIdList></Reference><Reference><Citation>Jatwani S, Hearth Holmes MP. Subacute cutaneous lupus erythematosus. In: StatPearls. Treasure Island (FL): StatPearls Publishing Copyright &#xa9; 2021, StatPearls Publishing LLC, 2021.</Citation></Reference><Reference><Citation>Franceschini F, Calzavara-Pinton P, Quinzanini M, et al. . Chilblain lupus erythematosus is associated with antibodies to SSA/Ro. Lupus 1999;8:215&#x2013;9. 10.1191/096120399678847632</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/096120399678847632</ArticleId><ArticleId IdType="pubmed">10342714</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>